We are pleased to have you join us for Epstein Becker Green’s Fifth Annual Counsel to Counsel roundtable, which will provide cutting-edge insights into the latest legal, regulatory, and compliance opportunities and challenges faced by general counsel in the health care and life sciences industries.
Supplemental materials for each presentation approved for CLE credit are available for download by clicking on the links below. Additional materials, not included on this page, will be provided in-person at the event.
Perspectives from CEOs/COOs and Board Members: “What Makes a Good Lawyer Into a Great General Counsel?”
1.5 California CLE Credit Hours (General)
1.5 New York CLE Credit Hours (Professional Practice)
Steven B. Epstein, Co-Founder of Epstein Becker Green
Michael Glosserman, former Managing Member of the JBG Companies
Gary St. Hilarie, CEO of Horizon Blue Cross Blue Shield of New Jersey
Michelle Hood, Executive Vice President and COO of the American Hospital Association
Dr. Harry Moon, Executive Vice President and COO of Nova Southeastern University
Todd Shamash, President and CEO of Capital Blue Cross
Download the Presentation Materials:
- 5 Things the Best General Counsel Do Differently
- Beyond the Law KPMG’s global study of how General Counsel are turning risk to advantage
- General Counsel as Senior Leaders
- How to Be a More Effective General Counsel
- New General Counsel – Top Ten Ways to Succeed
- The Future of Legal: 6 Shifts GC Must Make by 2025
- What I want from my general counsel – a CEO’s perspective
Diversity, Equity & Inclusion: Turning Aspiration into Action
1.5 California Elimination of Bias CLE Credit
1.5 New York CLE Credit Hours in Diversity, Equity and Inclusion
Bernadette Beekman, Director of Business Development at Legal Innovators
Dr. Renee Blake, Co-Founder of United Solutions Consultancy Group
Dr. Kenneth Saunders, Co-Founder of United Solutions Consultancy Group
Brian McComak, Chief Executive Officer and Founder of Hummingbird Humanity
Download the Presentation Materials:
- Diversity, Inclusive Leadership, and Health Outcomes
- Executives Role in Diversity Equity and Inclusion
- Increasing and Sustaining Racial Diversity in Healthcare Leadership
- Quick Overview – GC Role in Shaping and Advancing Corporate Culture in the Legal Department
- The Leader’s Guide to Corporate Culture
- The provider organization’s guide to diversity, equity, and inclusion
Added May 19, 2022
- A Guide to ERGs & Best Practices
- Addressing + Responding to Anti-Blackness: Shifting from Ally to Accomplice
- Engaging and Elevating Black Employees
- Exploring Culture Through Different Lenses
- Inclusive Language Guide
- Representation Matters: Reframing Diversity and Inclusion for Today's Workplace
Added May 22, 2022
Added May 23, 2022
- "Meet the student bringing Black illustrations to the medical field"
- Barriers to Health Care for Transgender Individuals
- Transgender Discrimination in Healthcare
- "Fact check: Father of modern gynecology performed experiments on enslaved Black women"
Ethics and Privilege in the "Real World" of Investigations and Litigation
1.5 California CLE Credit Hours (General)
1.5 New York CLE Credit Hours (Professional Practice)
James P. Flynn, Managing Director, Epstein Becker Green
The Honorable Karen K. Peters, Of Counsel, Epstein Becker Green
Rebekah N. Plowman, General Counsel of StimLabs
Richard W. Westling, Member of the Firm, Epstein Becker Green
Download the Presentation Materials:
- In re Kellog Brown & Root, Inc. :796 F.3d 137
- United States of America, ex rel. Elin Baklid-Kunz v. Halifax Medical Center and Halifax Staffing, Inc. 2012 WL 5415108
- Special Master’s Report and Recommendation No. 10 Regarding Plaintiffs’ Motion to Compel United Airlines, Inc. to Produce or Un-redact Certain Documents from Its Core Production Privilege Log in IN RE DOMESTIC AIRLINE TRAVEL ANTITRUST LITIGATION, MDL Docket No. 2656 Misc. No. 15-1404 (CKK) (February 2020)
- Remarks from Assistant Attorney General Kenneth A. Polite Jr. on Corporate Compliance and Enforcement (March 2022)
- U.S. Department of Justice Criminal Division – Evaluation of Corporate Compliance Programs (June 2020)
- Remarks from Deputy Attorney General Rod J. Rosenstein on the Foreign Corrupt Practices Act (November 2018)
- Remarks from Deputy Attorney General Lisa O. Monaco on White Collar Crime (October 2021)
- Office of the Deputy Attorney General Memorandum on Corporate Crime Advisory Group and Initial Revisions to the Corporate Criminal Enforcement Policies (October 2021)
- Remarks from Attorney General Merrick B. Garland on White Collar Crime (March 2022)
- Drug & Chemical Evaluation – Nalbuphine Hydrochloride (December 2019)